Scott Kasner, MD
Vascular Neurology · Philadelphia, PANPI 1285666412
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $174,002 of the $209,602 with a category attached, or 83.0%. 22 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 35.0% of the total. Reporting peaked in 2020 at $72,876 and has fallen 53.8% since, to $33,676 in 2025. Among vascular neurology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $1091.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$73K
- AstraZeneca$37K
- Medtronic$19K
- Bayer$14K
- Shionogi Inc$13K
- AbbVie$10K
- plus $44K from 16 others
Across 165 payments — averaging $4386.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$374K
- Medtronic$174K
- Genentech, Inc.$103K
- Sunovion Pharmaceuticals Inc.$54K
- Artivion, Inc.$14K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- plus $3K from 4 others
What the payments were for
- Consulting fees$174,00283%
- Speaking & faculty fees$12,5506%
- Grants$2,5001%
- Travel & lodging$16,5898%
- Food & beverage$3,9612%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 22 | $73,280 |
| AstraZeneca | 15 | $36,770 |
| Medtronic(3 entities) | 28 | $18,817 |
| Bayer | 32 | $13,513 |
| Shionogi Inc | 3 | $12,904 |
| AbbVie | 6 | $9,900 |
| Janssen Global Services, LLC | 10 | $7,749 |
| W. L. Gore & Associates, Inc. | 19 | $7,503 |
| Abbott | 14 | $7,474 |
| Astrazeneca UK Limited | 1 | $3,500 |
| Argenx US, Inc. | 1 | $3,450 |
| Portola Pharmaceuticals, LLC | 9 | $3,293 |
| Stryker | 2 | $2,400 |
| Genentech, Inc. | 2 | $1,840 |
| Boehringer Ingelheim International GmbH | 5 | $1,542 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $1,350 |
| Artivion, Inc. | 2 | $1,300 |
| Sumitomo Pharma America, Inc. | 1 | $1,245 |
| Alnylam Pharmaceuticals Inc. | 11 | $1,129 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $365 |
| Biogen | 2 | $149 |
| Philips North America LLC | 4 | $130 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOKELMA$25,550
- S-005151$10,054
- AMPLATZER TALISMAN$7,283
- Product in Development$6,863
- ANDEXXA$5,148
- BRILINTA$3,222
- WINGSPAN$2,400
- TNKase$1,820
- AMDS-Ascyrus Medical$1,300
- ORGOVYX$1,245
- UBRELVY$1,100
- CARDIOFORM Septal Occluder$500
- OFEV$365
- LINQ II$303
How this compares
$209,602 in reported general payments places this provider in the 95th percentile of 52 vascular neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $28,973 |
| XareltoRivaroxaban | 12 | $8,600 |
| Atorvastatin Calcium | 13 | $310 |
| Donepezil Hcl | 24 | $269 |
| ClopidogrelClopidogrel Bisulfate | 13 | $161 |
| Amlodipine Besylate | 12 | $78 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Philadelphia
- Michael McGarveyPhiladelphia$15K
- Steven MessePhiladelphia$14K
- Donna GeorgePhiladelphia$4K
- Brett CucchiaraPhiladelphia$2K
- Sydni ColePhiladelphia$408
- Paul NovelloPhiladelphia$122
- Christopher FavillaPhiladelphia$109
- Kelley HumbertPhiladelphia$85
- Qingyang YuanPhiladelphia$79
- Laura SteinPhiladelphia$64
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.